A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy.
INTRODUCTION:Allergic rhino-conjunctivitis (ARC) is an IgE-mediated disease that occurs after exposure to indoor or outdoor allergens, or to non-specific triggers. Effective treatment options for seasonal ARC are available, but the economic aspects and burden of these therapies are not of secondary...
Main Authors: | Massimo Bilancia, Giuseppe Pasculli, Danilo Di Bona |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0232753 |
Similar Items
-
Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
by: Andrzej Bożek, et al.
Published: (2017-12-01) -
Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid
by: Radoslaw Gawlik, et al.
Published: (2016-08-01) -
Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy
by: Sviatlana Starchenka, et al.
Published: (2019-11-01) -
Allergoid preparations for allergen immunotherapy: A brief overview
by: S N Gaur
Published: (2018-01-01) -
Artemisia vulgaris pollen allergoids digestibility in the simulated conditions of the gastrointestinal tract
by: Ćirković-Veličković Tanja D., et al.
Published: (2006-01-01)